Literature DB >> 30196535

CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.

Ryoya Yamaoka1, Takamichi Ishii1, Takayuki Kawai1, Kentaro Yasuchika1, Yuya Miyauchi1, Hidenobu Kojima1, Hokahiro Katayama1, Satoshi Ogiso1, Ken Fukumitsu1, Shinji Uemoto1.   

Abstract

BACKGROUND AND OBJECTIVES: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. However, its prognosis remains poor. Expression of cluster of differentiation 90 (CD90) has been identified as an indicator of poor prognosis in many cancers. Here, we examined the importance of CD90 expression in ICC.
METHODS: We performed immunohistological assays for CD90 in human ICC surgical specimens and assessed its relationship with clinicopathological findings and prognosis. Moreover, we analyzed the characteristics of CD90+/- cells, mainly with respect to metastatic potential, using human ICC cell lines.
RESULTS: CD90 expression was significantly associated with lymph node metastasis and was revealed to be an independent prognostic factor. The CD90+ cells present in ICC specimens did not appear to be cancer-associated fibroblasts, as they did not express α-smooth muscle actin. In vitro, CD90 + cells exhibited greater migratory ability and higher expression of epithelial-mesenchymal transition (EMT)-related genes, including CXCR4 and MMP7, than CD90- cells. Wnt/β-catenin signaling pathway activation was also heightened in CD90+ cells. In such cells, EMT appeared to be induced by CXCR4 and MMP7 expression through activation of Wnt/β-catenin signaling.
CONCLUSION: CD90+ cells demonstrate high metastatic potential owing to Wnt/β-catenin signaling activation and are associated with poor prognosis in ICC.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Wnt/β-catenin signaling; cluster of differentiation 90; epithelial-mesenchymal transition; intrahepatic cholangiocarcinoma; lymph node metastasis

Mesh:

Substances:

Year:  2018        PMID: 30196535     DOI: 10.1002/jso.25192

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Identification of prognostic factors for intrahepatic cholangiocarcinoma using long non-coding RNAs-associated ceRNA network.

Authors:  Zhichen Kang; Lixin Guo; Zhuo Zhu; Rongfeng Qu
Journal:  Cancer Cell Int       Date:  2020-07-16       Impact factor: 5.722

2.  Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold.

Authors:  Takahito Minami; Takamichi Ishii; Kentaro Yasuchika; Ken Fukumitsu; Satoshi Ogiso; Yuya Miyauchi; Hidenobu Kojima; Takayuki Kawai; Ryoya Yamaoka; Yu Oshima; Hiroshi Kawamoto; Maki Kotaka; Katsutaro Yasuda; Kenji Osafune; Shinji Uemoto
Journal:  Regen Ther       Date:  2019-03-30       Impact factor: 3.419

3.  CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis.

Authors:  Tatsunori Miyata; Yo-Ichi Yamashita; Tomoharu Yoshizumi; Masayuki Shiraishi; Masayuki Ohta; Susumu Eguchi; Shinichi Aishima; Hikaru Fujioka; Hideo Baba
Journal:  Cancer Sci       Date:  2019-08-13       Impact factor: 6.716

4.  Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome.

Authors:  Artur Mezheyeuski; Ulrika Segersten; Lina Wik Leiss; Per-Uno Malmström; Jiri Hatina; Arne Östman; Carina Strell
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

5.  CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.

Authors:  Serena Mancarella; Grazia Serino; Isabella Gigante; Antonio Cigliano; Silvia Ribback; Paola Sanese; Valentina Grossi; Cristiano Simone; Raffaele Armentano; Matthias Evert; Diego F Calvisi; Gianluigi Giannelli
Journal:  J Exp Clin Cancer Res       Date:  2022-02-16

6.  Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.

Authors:  Hualian Hang; Seogsong Jeong; Meng Sha; Defu Kong; Zhifeng Xi; Ying Tong; Qiang Xia
Journal:  Ann Transl Med       Date:  2019-12

7.  Flotillin-2 predicts poor prognosis and promotes tumor invasion in intrahepatic cholangiocarcinoma.

Authors:  Zhiying Xu; Tao Wang; Haiyang Song; Xuewen Jiang
Journal:  Oncol Lett       Date:  2020-01-24       Impact factor: 2.967

8.  Prognostic and clinicopathological value of CD90 expression in cancer patients: a systematic review and meta-analysis.

Authors:  Hyun Min Koh; Hyun Ju Lee; Dong Chul Kim
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.